Navigation Links
Whooping Cough Vaccine Less Effective Over Time: Study
Date:11/27/2012

By Serena Gordon
HealthDay Reporter

TUESDAY, Nov. 27 (HealthDay News) -- Vaccination does safeguard children against whooping cough, but its protective effect seems to lessen over time, new research finds.

The 2010 outbreak of whooping cough (pertussis) in California, which sickened more than 9,000 people and left 10 infants dead, prompted an examination of the current vaccine's effectiveness. That study concluded that the vaccine is effective but loses power over the years, leaving children 7 to 10 years old particularly susceptible.

"The pertussis vaccine is our best protection against disease," said the study's lead author, Lara Misegades, an epidemiologist at the U.S. Centers for Disease Control and Prevention in Atlanta. "We found that unvaccinated children were eight times more likely to be a pertussis case than vaccinated children. Parents should ensure children complete the childhood series and make sure your children get the adolescent booster too."

In the United States this year, more than 36,000 whooping cough cases have been reported, including 16 deaths -- most in infants younger than 3 months old, according to the CDC.

Because the vaccine's protective shield diminishes over time, health experts have suggested that the current vaccine dosing schedule may need reevaluation.

"We're continuing to evaluate the changing epidemiology [of pertussis], but it's too early to speculate if there's a need for an additional booster," Misegades said.

Results of the study appear in the Nov. 28 issue of the Journal of the American Medical Association.

The vaccine, commonly referred to as the DTaP vaccine, also includes immunizations for diphtheria and tetanus. It is given in a five-dose series at 2, 4 and 6 months; at 15 to 18 months; and between 4 and 6 years. An adolescent booster is recommended between age 11 and 12.

The current study was designed to evaluate how long it had been between the last DTaP vaccination and the development of pertussis in patients involved in the California outbreak, the state's largest in 60 years.

The study included data from 15 California counties with a high incidence of whooping cough cases. A total of 682 children aged 4 to 10 years who had pertussis were included, and for each of these children three kids of the same age from the same physician practice who did not have pertussis were selected for comparison.

The researchers found that, compared to the controls, children who had contracted whooping cough were 89 percent less likely to have received all five doses of the vaccine. Children with the disease were more likely to be unvaccinated compared to those without the disease -- 7.8 percent versus 0.9 percent, according to the study.

The researchers also found that the more time that had passed since vaccination, the less effective the vaccine appeared to be.

"Within the first few years, the vaccine's efficacy was around 98 percent," Misegades said. "Five or more years out, the vaccine effectiveness had dropped to about 71 percent."

Seven- to 10-year-old children had the highest incidence of disease, and incidence increased with age. About 3 percent of the cases occurred in 4-year-olds, while 31 percent of the cases were in 10-year-olds.

The current vaccine is an acellular vaccine, and it doesn't contain whole cells of the bacterium responsible for pertussis infections. The previous vaccine did contain whole cells of the bacterium, but was more likely to cause side effects, according to the study.

The switch to the acellular vaccine may partly explain the resurgence of pertussis, according to an accompanying journal editorial, but other factors may also be involved. Better diagnosis may also play a role, Dr. Eugene Shapiro, a professor of pediatrics and epidemiology at the Yale University School of Medicine, wrote in the editorial.

Dr. Kenneth Bromberg, director of the Vaccine Study Center at the Brooklyn Hospital Center in New York City, agreed that the whole-cell vaccine may have been more effective than the acellular vaccine, although he pointed out that the whole-cell vaccine sometimes had production issues and one batch of vaccine wasn't always as effective as another. And, he said, the components of that vaccine that may have increased effectiveness may be the very ones that also increased the risk of side effects.

The takeaway message for parents, Bromberg said, is that "the vaccine works. It's effective, so make sure everyone is appropriately vaccinated according to the current schedule."

"We'll have to wait for further study to [determine if the current dosing schedule needs change]," he said. "Parents should stay tuned as to whether we recommend additional vaccinations for pertussis."

More information

Learn more about pertussis vaccines from the U.S. Centers for Disease Control and Prevention.

SOURCES: Lara Misegades, Ph.D., M.S., epidemiologist, U.S. Centers for Disease Control and Prevention, Atlanta; Kenneth Bromberg, M.D., chairman, pediatrics, and director, Vaccine Study Center, Brooklyn Hospital Center, New York City; Nov. 28, 2012, Journal of the American Medical Association


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. What did we learn from the 2010 California whooping cough epidemic?
2. Whooping Cough Cases Reaching Record Highs: CDC
3. Is Improved Vaccine Causing Whooping Cough Outbreaks?
4. Whooping Cough Vaccine Protection Fades Over Time: Study
5. CDC Panel: All Pregnant Women Should Get Whooping Cough Shot
6. Honey a Sweet Treatment for Kids Night-Time Cough
7. Secondhand Smoke May Impair Childrens Cough Reflex
8. Chronic Cough Responds to Epilepsy Drug, Study Finds
9. Prenatal exposure to pesticide additive linked with childhood cough
10. Antibiotics Dont Ease Coughs in Kids With Common Cold: Study
11. Study Suggests Vaccine May Help Kids With Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Whooping Cough Vaccine Less Effective Over Time: Study
(Date:2/11/2016)... ... , ... The president released a FY 2017 budget request on Tuesday that ... the cost burden to military beneficiaries. , MOAA’s president, retired Air Force Lt. ... including limited quantifiable benefit fixes mixed with numerous beneficiary fee hikes. , “We were ...
(Date:2/11/2016)... ... 2016 , ... The Chartis Group, a national advisory services ... the “2015/2016 Best in KLAS: Software and Services” report in two categories: IT ... insights firm on a global mission to improve healthcare delivery by amplifying the ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... to reverse diabetes has been gearing up for their simultaneous grand openings in ... It’s about right now that you’re probably wondering, is reversing diabetes possible? According ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... advocates will discuss how to improve care by making data on heart procedures ... disease. The Summit on Transparency and Public Reporting of Pediatric and Congenital Heart ...
(Date:2/11/2016)... ... February 11, 2016 , ... Thermi™, a world leader ... to announce the promotions of Allison Kelly to executive vice president of the ... vice president of North American capital sales, and Wendy Oseas to vice president ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... , Feb. 11, 2016 Potrero Medical, Inc., ... pleased to announce the appointment of George M. Rapier, ... San Antonio, TX , WellMed is one of ... 200,000 patients and HMO members in Texas ... in 1990 out of his own internal medicine practice, he ...
(Date:2/11/2016)... , Feb. 11, 2016  NOIT™ Research LLC, a ... "Gift of Change" campaign to assist needy families in ... such unit sold between February 10, 2016 and March ... a needy family. The NOIT is an auditory stimulus ... individuals develop language skills. Beth Shier ...
(Date:2/11/2016)... , Feb. 11, 2016  MiMedx Group, Inc. ... utilizing human amniotic membrane and other birth tissues, human ... to develop and market advanced products and therapies, announced ... Markets, 2016 Global Healthcare Conference in New ... and CEO, Michael J. Senken , Chief Financial ...
Breaking Medicine Technology: